This article was originally published in The Gray Sheet
Executive SummaryReceives FDA approval for the Synchrony III rate-modulated dual-chamber and Solus II rate-modulated single-chamber pulse generators. The Synchrony III weighs 30 grams and is compatible with implantable cardioverter defibrillators. The Solus II, which weighs 25 grams, "is among the smallest pulse generators" in the U.S., Siemens claims. Both devices can be used with Siemens' PDx software to provide diagnostic information, such as event histories, that "may reduce the need" for Holter monitoring, the firm says.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.